Improvement of human health is what guides and motivates us at Bayer. We’re dedicated to continually improving our offerings of therapeutic products that address complex medical conditions such as hemophilia, multiple sclerosis and macular degeneration. At the same time, we’re invested in research and development of new treatments and in expanding scientific and clinical knowledge that will improve patient care and outcomes.